SAKRA WORLD HOSPITAL SIGNS MoU WITHPARTNERS MEDICAL INTERNATIONAL

1.Collaboration to bring world-class practices and protocols in management of Heart Diseases. 2.Global experts find common ground at the Sakra Cardiac Confluence. 3.International best practices, experience, expertise and knowledge sharing opens new possibilities of treatment options for Indian patients.

Bangalore, 11th November 2014:Sakra World Hospital, a joint venture of the Kirloskar group, Toyota Tsusho Corporation, and SECOM of Japan has joined hands with Partners Medical International, the academic arm of Partners HealthCare, one of the leading non-profit health care systems in the USAand associated with Harvardaffiliated Hospitals like Massachusetts General Hospital and Brigham and Women’s Hospital, Boston to bring world-class treatment options for heart patients in India.

Under this new collaboration, Sakra World Hospital shall look into widening the possibilities of treatments for End Stage Heart Failure patients in India through exchange of knowledge, experience, expertise, processes, protocols sharing technical knowledge on the subject. It will also enable academic exchange programme between participating institutes and overview of quality systems and JCI guidelines to help in the process of JCI accreditation.

Further Dr. Raajiv Singhal, Group CEO - Sakra World Hospital announced the launch of Heart Failure Clinic at Sakra World Hospital to address the epidemic of heart disease in India “End stage heart failure carries high mortality and morbidity. Patients suffering from end stage heart failure are frequently in and out of hospitals and have very poor quality of life. For these patients all medical options should have already been exhausted barring heart transplant and LVAD (high end devices that support the heart function), both of which are still in infancy stage in India. We are pleased to launch Heart Failure Clinic at Sakra which is our first step towards establishing a Heart Transplant Program”

In full attendance by the experts from the healthcare industry, the 2-day confluence isseeing the speakers highlighting new treatments and techniques in managing Chronic Total Occlusions (CTO), Stroke Program, Interventional Cardiology, Multivessel disease, Revascularisation which were discussed at length. Thus broadening the scope of treatment of difficult cardiac disorders like the end stage heart failure, CTO and diffused coronary disease.

Further, the discussions focused on the logistics, administrative and other challenges in the development of heart transplant programme in India. Specialists from Sakra World Hospital showcased the work already being done here.

For more on the conference and details, log on to: http://sakraworldhospital.com/cardiac-confluence/

About Sakra World Hospital:

Sakra World Hospital is a joint venture of the Kirloskar group, Toyota Tsusho Corporation, and SECOM of Japan.

Toyota Tsusho Corporation is member of the world renowned Toyota group with a turnover of $60 billion and a diverse business presence in industrial, commercial, and consumer sectors.

SECOM Medical System is a 100 per cent subsidiary of SECOM, a leading company in home & business security solutions and services. SECOM Medical System with 2 decades of healthcare experience owns 18 multi-specialty hospitals with 5500 beds and state-of-the-art rehabilitation centres across Japan.

The synergies of these three large entities are being channelized to provide the best of healthcare and brining about a change in the current systems and processes in the healthcare delivery.

Sakra World Hospital is a 350-bed hospital, providing healthcare across all specialties such as Neuro sciences, Cardiac sciences, Orthopedics, women and child health, Digestive and Hepatobiliary sciences, Renal Sciences, emergency and trauma care.

There are 12 integrated modular operation theatres (OTs) with cutting-edge, state-of-the-art technologies like OR integration solution that features video input recording, saving and displaying from a range of sources like surgical camera, peripheral camera and MIS camera.

The OT complex has a dedicated world-class hybrid OT, featuring an advanced bi-plane cathlab and a fixed column OT table with common iso-centre for high-precision surgeries. The procedures using bi-plane cathlab, enable visualization of smaller body parts like thin vessels of the heart and facilitates intra-operative 3D imaging.

The 80 ICU beds are supported by high-end equipment with a central monitoring system. This facilitates quick and easy collection / access and transmission of patient's data to any department in the hospital network. There are dedicated isolation rooms for patients who are highly infection prone.

The 24-hour level 1 emergency and trauma care unit, the first of its kind, is top-notch. To enhance the response time for medical emergencies, the triage area (casualty), resuscitation area (revival), ICU and OT are all located on the same floor. The emergency bay has a mini lab / static lab facility with critical equipments such as blood gas analyser, cell counter etc., to empower doctors in taking quicker and better informed decisions.

For further details contact: Soundhariya Viswanathan: 9620362345


Contact Details

Company Name: SAKRA WORLD HOSPITAL
Issued By: Moksha Event
Phone: 9620362345
Address: The Taj West End 25,Race Course Road, Bengaluru, Karnataka 560001
City: Bangalore
State: Karnataka
Zip: 560001
Country: India
Website: Visit the website

Keywords : Sakra Cardiac Confluence, Heart Failure Clinic, Heart Transplant Program, Chronic Total Occlusions,

by Moksha Event (few years ago!)

Latest Press Releases

The Mad Hatter Now Offer a Full Line of Hearth Products and Full Line of Grills

Diabetes Insulin Delivery Pens Market Research Report 2018

Dr Kapadia Provides Tips to Patients Interested in Hair Transplant Procedures

love vashikaran specialist

Solar Blanket Sales Market Report 2018

Spring Bottled Water Market Insights, Forecast to 2025

Biochemical Incubator Sales Market Report 2018

Quinine Sulphate Sales Market Report 2018

Automotive Chassisc System Market Insights, Forecast to 2025

2,6-Dicarboxypyridine market size in key regions like North America, Europe, Asia Pacific an..

Remove this press release ?

Due to extra work required to remove the press-releases we have started charging $1.99 for press release removal.

Your press release will be removed in 24 hours, once the payment has been received.

Search Press Release
e.g. Business, Computer, etc.